These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 27364616
1. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. Tanriover B, Jaikaransingh V, MacConmara MP, Parekh JR, Levea SL, Ariyamuthu VK, Zhang S, Gao A, Ayvaci MUS, Sandikci B, Rajora N, Ahmed V, Lu CY, Mohan S, Vazquez MA. Clin J Am Soc Nephrol; 2016 Sep 07; 11(9):1650-1661. PubMed ID: 27364616 [Abstract] [Full Text] [Related]
11. Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States. Riad S, Jackson S, Chinnakotla S, Verghese P. Pediatr Transplant; 2021 Aug 11; 25(5):e13928. PubMed ID: 33314638 [Abstract] [Full Text] [Related]
12. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy. Hussain SM, Marcus RJ, Ko TY, Nashar K, Thai NL, Sureshkumar KK. Exp Clin Transplant; 2016 Jun 11; 14(3):287-93. PubMed ID: 27221720 [Abstract] [Full Text] [Related]
15. Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death. Peng W, Liu G, Xie W, Huang H, Wu J, Shou Z, Chen J. Int J Clin Pract Suppl; 2015 May 11; (183):23-8. PubMed ID: 26177071 [Abstract] [Full Text] [Related]
16. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States. Riad S, Jackson S, Chinnakotla S, Verghese P. Pediatr Transplant; 2021 Aug 11; 25(5):e13925. PubMed ID: 33333629 [Abstract] [Full Text] [Related]
17. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin. Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D. Transplant Proc; 2010 Aug 11; 42(6):2006-8. PubMed ID: 20692393 [Abstract] [Full Text] [Related]
18. Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants. AbdulRahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, MacConmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B. Liver Transpl; 2019 Mar 11; 25(3):411-424. PubMed ID: 30506870 [Abstract] [Full Text] [Related]
20. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal. Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S. Pharmacotherapy; 2011 Jun 11; 31(6):566-73. PubMed ID: 21923440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]